Imperial Brands PLC (IMB) Earnings Call Transcript & Summary

November 17, 2020

London Stock Exchange GB Consumer Staples Tobacco earnings 71 min

Earnings Call Speaker Segments

Stefan Bomhard

executive
#1

Morning, everyone, and welcome to the presentation. Thanks for being here at my first results presentation as Imperial CEO. I regret that we aren't able to meet face to face today, but I'm really looking forward to that happening down the road. With me today are Oliver Tant, our Chief Financial Officer, and Peter Durman, our Investor Relations Director. Before we begin, I imagine some of you may be wondering why I accepted this role and what I believe I can offer Imperial. Most of my career has been spent in consumer goods. My start was at Procter and Gamble, and I've held a variety of senior sales, marketing, and general management positions at a diverse set of consumer-facing businesses — Burger King, Unilever, Cadbury, and Bacardi. So I think I come with many years of sales and marketing experience. And as the first external CEO at Imperial, I offer a fresh perspective with which to test and challenge the business. I'm determined that we will deliver our full potential for all our stakeholders. I'm also a person who is passionate about delivery. I firmly believe that a commitment is a commitment. And I've always been focused on making sure we do our utmost to deliver against our promises.

Stefan Bomhard

executive
#2

That gives you a little context on who I am and how I work. So, what drew me to Imperial? Several things appealed to me. First, Imperial is a solid company with strong assets and strong people. The issue is that for a number of years it has been underperforming, and the chance to reverse that is extremely attractive to me. I have also always liked being in businesses and sectors undergoing change. That is definitely true of Imperial and Tobacco. As CEO at Inchcape, I was able to guide the company through a transforming automotive sector and to reshape the organization so it played to its strengths. From my time at Bacardi I bring experience of the heavily regulated spirits sector, where you must handle the difficulty of marketing products in dark markets too. I also like being in businesses that are not the market leaders. And where there is a genuine opportunity to take the business forward, companies where you frequently have to work harder and smarter to pinpoint the competitive point of difference and what gives you the right to win. Burger King, for instance, was a distant number two to McDonald's.

Stefan Bomhard

executive
#3

Bacardi, much like Imperial, held the number four position worldwide within its sector. That gives Imperial plenty of appealing traits in my view. Since the very first day, my attention has been on tackling the problems that must be settled so we can achieve better, steadier results as time goes on. This morning I'll share my early takeaways regarding the business and lay out when our strategic review will unfold. Let me be direct, though: although that review is progressing nicely, it remains unfinished, and the plans—the components needed to build a stronger company—are still being completed. Even so, several improvement areas and changes already in motion have become clear to me. Some of those areas I'll walk you through today. I'll likewise offer background on this set of results, covering an evaluation of COVID-19's effects and the way it is shaping what consumers do. After that I'll mention how we are doing on our ESG obligations, then pass things to Oliver, who will walk everyone through the results personally. Following that, I'll give our 2021 outlook along with our priorities. As always, we'll wrap up with your questions. So let me begin with what I set out to do across my first four months.

Stefan Bomhard

executive
#4

The first thing I wanted to do was get out into our markets and learn the business. Because of the coronavirus, most of those visits had to happen virtually, though I did manage to see all of our most important European markets in person. In recent months, I've sat down with each of our 12 cluster teams and every one of our major functions, hosting roughly 300 meetings, whether virtual or physical. Wherever I went for meetings, I ran online employee channels, and that let me connect with thousands of employees across the world — hearing what they think, what they're struggling with, and taking their questions. I also made sure to meet a range of stakeholders — consumers, retail partners, competitors and shareholders — so I could form a clear picture of the business and of how we are perceived. Another focus has been collecting and absorbing as much data as possible — and that's a lot of it. Basing our decisions on real data and insight matters. To start tackling the performance and execution issues, I've already set up monthly business reviews with the divisions and our top five markets, which embeds a far more rigorous way of tracking performance. I'm already bringing a stronger sense of discipline to how we monitor progress and deliver against our commitments.

Stefan Bomhard

executive
#5

Accountability for delivery is one topic colleagues have brought up with me. As part of shifting the culture at Imperial, this is among the key elements I am now aiming to improve. And a scene — I will return to you shortly on that. I understand that certain areas, culture among them, need time before they change. Even so, I am already pursuing better outcomes through a stronger focus on performance management and by reworking incentive structures. Leading the full strategic review of the business, with support from my colleagues, has been one of my biggest priorities. That will remain our central focus over the months ahead. And as you may have noticed in last month's Trading Update, I have been working to reinforce my Executive Team, with several new senior leaders arriving from outside the industry. In my view it is critically important that we bring in fresh ways of thinking, especially since our industry is changing so much, and we have plenty of tobacco expertise in the organization, which matters. But we are now adding to that by bringing in new skills, capabilities and experience from developing other consumer goods businesses. For example, Javier Huerta will bring more than 20 years of experience at Nestle and Unilever in reconfiguring supply chains to adapt to changing consumer needs, and in developing new supply chains for new product segments important for addressing our NGP strategy.

Stefan Bomhard

executive
#6

I've worked alongside Alison at Inchcape, so I've witnessed directly the way she can help push through the organizational and cultural change needed to back our strategic objectives. Murray McGowen holds the position of Imperial's First Head of Strategy; he comes from a strategy consultancy background, having spent time at McKinsey, and he also brings extensive FMCG experience. In a comparable vein, Therese has moved to strengthen our Board, having recently appointed two new NEDs, and both of them bring a wealth of international business experience. So, while I'm not yet able to fully share all of my thinking with you today, I'd like to take a moment to give you some initial observations regarding the business. Let me say right at the start that I recognize the disappointment surrounding performance and valuation. We will tackle this over time. And my first four months have reinforced my belief in the future value creation potential of Imperial. For instance, Tobacco is demonstrating its resilience in these uncertain times. And although there will always be some regulatory uncertainty, I'm confident that the tobacco pricing model remains intact and can support increasing returns going forward. We have a solid business with good brands, high margins, and strong operating cash flow, and all of this underpins the opportunity to deliver a stronger and more consistent performance over time.

Stefan Bomhard

executive
#7

I know there's a debate about whether these brands are underinvested. But it's also important to keep in mind that marketing spend in the tobacco sector is a relatively low percentage of revenue compared to other consumer sectors. So adjustments to spend are unlikely to be significant over time in the context of our high margins. With exposure to some highly attractive markets, such as the U.S. and Germany, both are large profit pools where consumer affordability is good, which supports future pricing opportunities. I believe that our manufacturing supply chain operations give us really core strengths in the tobacco business. The team has delivered consistently and coped admirably, for example, with the challenges of the coronavirus, with the vast majority of our factories operating throughout with minimal disruption. I also believe they're run relatively efficiently despite the complexity of the business. Our approach to customer engagement is also a real strength. I have spoken personally to many of our customers at length, which has provided real insight. In talking to customers, they really value the insight around the product and the support that Imperial brings on areas such as regulation, helping to build solid retail and wholesale relationships.

Stefan Bomhard

executive
#8

I think that strength matters a great deal in tobacco, because of how much influence retailers have over which brands and products consumers pick, especially in dark markets. Since Imperial is usually the number two or number three player in that country, I found that customers like partnering with us to create good competitive tension on shelf. I think we can build on the strengths going forward. In the U.S., for example, how much our sales force covers varies a lot from state to state. So there is an opportunity to allocate resources more effectively. Well in Germany, our sales team need to be better aligned to the fastest growing channels and outlets. One of our big German retail customers also comment to me that he has not met with a senior Imperial leader in many years. I'm determined to make sure we stay close to all our customers. This is my DNA, and has critically build a strong and competitive business. I've also been impressed with the commitment and passion of our employees across the business, and also the warm welcome I've received. Our people have done a great job in embracing new ways of working in these uncertain times. For example, our sales force adopted their approach to meet and serve customers.

Stefan Bomhard

executive
#9

While visiting our sales team in Madrid, they explained to me how we adapted fastest at outlet coverage when COVID hit. Overall, I met strong people on the ground, and we need to empower them and hand them more accountability. I also want to speak frankly about several problems I believe must be tackled. In Tobacco, share results have been uneven across the past five years — we frequently gained share in markets contributing relatively little financially, such as Russia and Saudi Arabia, yet lost share in several bigger contributors, including Germany and UK. We have to produce steadier outcomes, especially in the markets that drive our overall financial delivery. That is a top priority. To sharpen alignment with this goal, I have already reworked how market share feeds into our bonus structure. It matters to acknowledge that we compete in a tough market, and shifting share performance will take time. Still, there is room to sharpen our consumer insight so it better shapes our marketing programs and yields stronger results. As part of lifting performance management in our major markets, we now examine marketing initiatives closely against their KPIs on a quarterly basis.

Stefan Bomhard

executive
#10

When it comes to NGP, our starting point is consumer preferences, and it's obvious that a large number of adult smokers are picking reduced risk alternatives over combustible tobaccos. As a consumer goods company, we have a chance to satisfy that consumer demand, so NGP has to be part of what we offer consumers, since that's where we can contribute meaningfully to harm reduction. That said, things have been difficult given an uncertain regulatory backdrop, low barriers to entry and a highly competitive environment. Those factors have certainly played a part, but our NGP business has underperformed, and the investment decisions we made have not delivered the returns we anticipated. We've already taken action on this by cutting investments to reduce the losses, while we assess our assets and capabilities. The NGP team and the markets have flagged areas to me where our execution can improve — for instance, by making sure we develop products that are sufficiently different and thoroughly tested before we scale them up widely. In this context, we will also keep being more disciplined with our investments. What's genuinely positive here, in my view, is that no company has yet found the NGP solution that truly meets the needs of adult smokers across the world. So there's more to play for, and with a more proven and disciplined business model, I'm confident I can build a stronger NGP business that provides returns to our shareholders.

Stefan Bomhard

executive
#11

Like I said before, performance has to be managed with more scrutiny. I’ve already started making changes to achieve that through in-depth monthly business reviews. That will let us move faster and adapt better when circumstances shift, and correct course if investments aren’t paying off. This has to be backed by sharper analysis, so that consumer insight informs our decisions. I discovered that we hold a wealth of detailed market share data at the brand level, yet it frequently isn’t used in a meaningful way to shape planning and decision making. All of this requires the right culture, with stronger accountability and clearer ownership of results, all underpinned by collaborative teamwork. We ought to look outward more, welcoming fresh thinking and learning from others. We also need to build in stricter discipline on returns that mirror the risk inherent in different business areas. Too often, tobacco investments were required to pay back over a fairly brief window, even though their risk profile was low and well understood. NGP investments, by contrast, were not subject to the same return requirements, despite the higher uncertainty. We need to put in place a framework that is more disciplined and focused on returns.

Stefan Bomhard

executive
#12

I'd also like to urge everyone to feel confident enough to be more transparent, to question accepted wisdom, and to be far more candid when assessing performance. I'm determined that the way we communicate should be balanced and open as well. Steps have already been taken to improve these results — within these results. And we will endeavor to do better. To sum up, there is a great deal we can accomplish, and I believe Imperial holds enormous potential. With sharper focus and stronger execution, over time we will be capable of generating long-term shareholder value. I'll be able to share far more of my thinking once a strategic review has concluded. As you'd probably anticipate, I'm examining every part of the business to explore ways of creating value. I'm coming at this with an open mind, acknowledging that the present strategy and business model have not been delivering. The consumer has to be placed at the heart of our thinking and planning, in recognition of their freedom of choice. In Tobacco, we're examining what provides us with competitive advantage across our footprint of markets, how brands are seen by customers and consumers, and what gives us the right to win in the market. I'm examining the part that NGP can play when it comes to giving consumers reduced risk alternatives to combustible tobacco.

Stefan Bomhard

executive
#13

My goal is for Imperial to take a meaningful part in harm reduction, and that requires a successful NGP business — one that is more focused and better managed. Regarding organizational capabilities, as I mentioned, we are looking into ways to strengthen the team and build our capabilities in certain areas, and to make sure the right organization structure is in place to deliver the strategy. Beyond the strategy, we also need to make sure our capital allocation supports strategic delivery, with the right mix of funding sources, the right investment levels, and appropriate returns to shareholders. We come out of this process with a clear strategy and priorities that will define what Imperial needs to do over the next couple of years and how we are confronting the challenges and seizing the opportunities ahead. We will give you a more detailed update on the review on the 27th of January. I know lots of you have lots of questions about these future plans, but you will understand that today I will be limited in what I can talk with you about. So now let me give you my perspective on this year's results. This has been a challenging year, and I recognize that these results fall short of original expectations.

Stefan Bomhard

executive
#14

On the positive side, tobacco consumer demand has held up well, and net revenue increased even as the business adjusted effectively to a fast-moving landscape brought about by the global pandemic. COVID-19 keeps touching and shaping every aspect of our lives, demanding adaptability and toughness. The dedication shown by each of our people in keeping operations running has truly impressed me. Our tobacco volume fell 2.1%, which mirrors certain short-term shifts in consumer behavior tied to COVID. We achieved share gains across the Group as a whole, and additionally, a good deal of that gain came in low value markets and products, producing a gross profit contribution weaker than anticipated. Additional COVID-19 related costs in manufacturing have likewise hit our profit delivery, along with some higher provisions after a cautious review of further risk amid continuing uncertainties. We furthermore incurred some extra regulator expenses and overhead investments that burdened our tobacco profitability, and Oliver will go through that in more detail. Although the NGP results are disappointing, we have delivered versus our revised expectation, and encouragingly, we are observing some sequential gains in sales progression during the second half. A more disciplined approach has cut investments substantially, which helped bring about a sizable decrease in losses over the second half.

Stefan Bomhard

executive
#15

There was also a bit of a delay, but the sale of the Premium Cigar business has now been completed, and that was a significant accomplishment given the conditions we're operating in. The €1.2 billion in proceeds will go toward supporting deleverage. Clearly, COVID has affected consumer behavior and market dynamics, shaping how and where people buy and use our products. With people spending more time at home and restrictions limiting opportunities for discretionary spending, it seems some consumers devoted a larger share of their income to tobacco. That pattern has been reinforced in certain markets such as the U.S., where stimulus payments gave consumer wallets a boost. Looking at it from a market and channel standpoint, it was obvious from the pandemic's outset that travel restrictions would sharply curtail sales in the duty-free channel, in Horeca outlets, and in markets that typically gain from seasonal holiday travel. The UK, Germany and France have seen benefits from some tourist volumes returning and from a decline in illicit trade. Our manufacturing supply chain has experienced some minor disruption from the pandemic, creating certain inefficiencies that Oliver will discuss. Clearly, we will be living with the virus for some time yet. And although I believe our business will prove resilient, we are taking a cautious view of the potential risks.

Stefan Bomhard

executive
#16

To close, I'd like to say a few words about ESG. It's my strong conviction that handling our ESG response well matters greatly for the success we aim to have going forward. In addition, given that the pandemic disrupted certain plant activities during the year, we will push further ahead across all 5 of the areas we have made priority focuses. Forming an ESG Steering Committee, led by Thérèse Esperdy and made up of senior people drawn from across the business, underlines how much ESG matters to the Board — as does our insistence that our auditors provide assurance on our ESG KPIs. If there is a single area that could be improved, it is the metric for certain priorities, climate and energy among them; on those we have very robust KPIs, but on some of the others we need to do better. That is going to change in this fiscal year. The Steering Committee has been working alongside the business to pinpoint and settle on suitable KPIs covering all of our main ESG issues. That piece of work is now finished. And after they have been validated against the new strategy, we will make them available to you. I'll now pass things to Oliver, who will take us through the numbers.

Oliver Tant

executive
#17

Thank you, Stefan. Good morning to all of you. It's been a tough year. Our Tobacco revenue came in a bit stronger than we had initially anticipated, yet that did not carry through to improved profits. Revenue from NGP likewise came in below what we had originally forecast. Even so, the cost-reduction actions we took have substantially lowered the losses during the second half, giving us a stronger foundation going forward. Within Tobacco, our overall market share rose by 50 basis points across the regions where we operate, and we achieved additional growth in most of our priority markets. A large portion of that increase, though, came from markets of lower value, which produced an unfavorable mix and a smaller gross profit contribution. On the whole, Tobacco net revenue rose 1.8%, helped by a robust second-half performance in the U.S. and by a return to growth in our AAA division. In NGP, revenue dropped 27% as we reduced trade inventories during the first half and as we pulled back on investment, especially in the second half. Profits and EPS were affected by NGP losses along with a decrease in Tobacco profits, which I'll address shortly. EPS fell 5.6%, a larger drop than the decline in operating profit, reflecting the somewhat higher tax rate for the year.

Oliver Tant

executive
#18

As we said before, I'm expecting that tax rate to keep climbing to roughly 23% in FY21. The dividend per share came in at 137.7p, which is 33% lower — that reflects the Board's choice to replace the dividend, something we announced back in May. Our headline cash conversion of 127% includes a 20% temporary gain from a shift in the timing of excise duty collections. Underlying cash conversion of 107% beat what we had expected, thanks to improvements in working capital. Tobacco volumes fell 2.1%, which is better than what we've seen in recent years. In Europe, volumes dropped 3.5%, with market size trends slightly better than expected, though that was offset by the significant COVID impact on our duty-free business. Just to remind you, our entire global duty-free business sits within the Europe division. We've also seen market size benefit from border closures, especially in Europe, where less illicit product has helped duty paid volumes in markets such as the UK. In the Americas division, volumes were down 3.3%. Looking at the U.S. market specifically, we saw a decline of 2.5% against a market size decline of 1.8%. Adjusting for the year-on-year impact of inventory movements in the U.S.

Oliver Tant

executive
#19

With 700 million sticks, we beat the market on volume, which works out to a 10 basis point share gain. In the AAA division, volumes were up 0.4%, driven by stronger sales in the Middle East and Africa that more than made up for softer volumes in Australia. Stefan noted that COVID has produced both winners and losers. Spain, the Canaries and the duty-free channel, for instance, have taken a hit, while Northern European markets and the U.S. have come out ahead. The coronavirus is plainly rising once more, which adds uncertainty around how consumer behavior and channel shifts could evolve from here. I'll cover how we've decided to account for that risk in a moment. Group share, as I said earlier, rose 50 basis points, and while we posted growth in seven of our 10 priority markets, the U.S. among them, we keep losing share in the UK and Germany. Still, our position in the UK is improving, with sequential growth helped by the launch of Lambert & Butler fine cut tobacco and a number of large value offerings across several of our cigarette brands. In Germany, we continue to reshape the portfolio, led by JPS and West, concentrating on value formats in fine cut as well as cigarettes.

Oliver Tant

executive
#20

The second half was stronger, yet we remain lower across the full year. For the first time in a number of years, we achieved share growth in Spain and France, where blond gains are now more than balancing the negative effect of dark formats. Our Italian share faced pressure because we raised JPS prices before competitors did. In the U.S., cigarette share rose for a second consecutive year. Continued Sonoma momentum and deep discount chiefly powered this, while Winston and Kool held their ground within the shrinking premium segment. Mass market cigars added 70 basis points, with backwards leading. Total market size fell 4.3%, as somewhat better results in H2, including the UK and U.S., were outweighed by steeper declines in markets including Australia and Spain. Net revenue overall increased 0.8% at constant currency. Tobacco net revenue rose 1.8%, helped by the slower pace of volume decline. Price mix at 3.9% came in below normal, mirroring unfavorable market and product mix, which I'll address shortly. NGP revenues dropped 27%, caused by supply chain destocking and reduced investment levels. Examining Tobacco price mix more closely, gross pricing stayed fairly steady throughout the year, as the full list appears here.

Oliver Tant

executive
#21

All in all, price mix faced a drag from negative market and portfolio mix, especially during the first half. Where market mix is concerned, it was a tale of two halves: better sales in lower value markets like the Middle East and softer sales in Australia combined to weigh on H1. A better mix of market volumes in the second half came about as sales rose in higher value markets in Northern Europe, while stronger volumes in the U.S. cushioned the effect of adverse market mix in AAA. On the product side, adverse mix resulted from stronger performance of our lower priced formats in the UK, Australia and Germany, and in the latter the private label brands contributed more than a billion sticks to our volumes while bringing in very little revenue. Product mix improved in H2 thanks to the turnaround in backward sales, which climbed over 30% in the second half. Turning to the divisions in more detail, Tobacco net revenue rose in the second half in every division apart from Europe, which felt the effect of lower sales in global duty free. Tobacco net revenue in the Americas was up 1.9%, helped by robust market volumes, continued strong pricing and additional share gains in both cigarettes and cigars.

Oliver Tant

executive
#22

For AAA, net revenue was up 5% versus a soft comparison period, driven by robust volume results across the Middle East and Africa plus better pricing conditions in Russia. We additionally gained from higher stock profits in Australia, which, as you may remember, carries over from 2019. As we look toward 2021, we anticipate this becoming a headwind of roughly £15 million on both revenue and profits versus the prior year. On NGP revenue, performance was impacted by lower investment during H2 along with trade destocking in the first half. On an encouraging note, after that destocking, revenue has risen sequentially during the second half in Europe as well as the U.S., while actual consumer off take has stayed broadly flat. Within AAA, the decline in the second half mirrors a halt in our rollout of Pulze and blu in Japan — the former while we assess the heated tobacco category as part of the strategic review. Adjusted operating profit fell 4.8% at constant currency. We restated the prior-year comparator by £10 million in order to remove the benefit from last year's Auxly revaluation. That stems from modifications to our adjusted performance measures that we announced last year. Tobacco profits came in £118 million lower. I'll give more detail on what drove this decline on the following slide.

Oliver Tant

executive
#23

Losses in our NGP business rose by £84 million. The main cause was write-downs on inventory, and those more than cancelled out the gains in underlying profitability that came from cutting costs and investment. Four key factors hit our Tobacco profits. Pricing held up well through the year, but price mix fell short of where we wanted it, weighed down by the negative product and market mix I mentioned before. In my estimation, that unfavorable mix dragged profit by roughly £50 million. COVID-related costs came to £90 million, and that figure includes approximately £25 million of manufacturing inefficiencies caused by disruption to how we normally work. We anticipate that a good number of these higher manufacturing costs will carry on into FY21. On top of that, we have booked provisions of about £65 million for possible stock and debtor risks tied to COVID-19. With stock, for instance, this concerns certain SKUs where consumer off take has dropped to much lower levels, so stock durations have risen sharply — duty free being one example. Given these risks, we have chosen on purpose to take a more cautious stance in an environment that is changing fast. Regulatory costs ran about £50 million above normal, pushed up by implementing track and trace under a EUTPD II and by inventory write-downs that followed the menthol ban in Europe.

Oliver Tant

executive
#24

In addition, we incurred certain industry fines tied to competition authority matters in the Netherlands and Ukraine, and we are challenging those. We anticipate roughly £20 million in regulation costs carrying into next year, largely connected to track and trace. Tobacco overheads came in higher too, since we directed more investment into the tobacco sales force. Within NGP, we recorded a further £29 million of write-downs during the second half, which lifts the full-year figure to £124 million. Those extra write-downs are likewise tied to slow moving inventory and IP. Operating losses came down substantially in the second half, thanks to cost cutting, lower investment and renegotiated trade margins with retailers. Cash conversion gained from a 20% temporary working capital benefit arising from the timing of duty payments in the UK on Logista. Apart from that benefit, which we anticipate unwinding in 2021, underlying cash conversion reached 107%, propelled by working capital improvements and reduced CapEx. As a reminder, we gain from a daily cash pooling arrangement with Logista. Across the year, the daily average cash balance under the Logista cash pooling arrangement stood at £1.9 billion, with movements ranging from a high of £3.9 billion down to a low of £0.5 billion.

Oliver Tant

executive
#25

When we closed out the year, our loan position stood at £2.4 billion. Net debt-to-EBITDA as reported, which took in temporary advantages from the timing of payments, came to 2.7 times. Strip out that benefit, and underlying gearing was 2.9 times. Once you factor in the money from the premium cigar sale — that deal closed after the year end — our pro forma net debt-to-EBITDA sits nearer to 2.7 times. Just to remind everyone, selling Premium Cigars will dilute next year's EPS by roughly 3%, and you can see that laid out on a slide in the appendices, where you'll also find guidance covering a range of finance items for the year ahead. With that, I'll hand things back to Stefan.

Stefan Bomhard

executive
#26

Thank you, Oliver. So looking ahead now, I anticipate stronger operational and financial results in 2021. On an organic basis, once you exclude what the Premium Cigar sale contributed, our expectation is low to mid single-digit growth in adjusted operating profit at constant currency. We recognize that COVID keeps imposing restrictions across the markets where we operate, and given that uncertainty, our forecasting for the year ahead has been deliberately cautious. Underlying tobacco pricing should stay strong. On top of that, ongoing mix headwinds will probably persist, along with a lower level of stock profits from Australia and the UK. We expect tobacco consumption to trend back toward more normalized levels, especially as the benefit of fiscal stimulus fades and potential recessionary pressures take hold. Given what travel looks like, we aren't assuming any recovery in our duty-free business this year. We also expect that COVID-19 restrictions will bring further manufacturing inefficiencies in the year to come. And in the same way, the regular costs tied to track and trace will keep going. We expect NGP losses to continue, but at the moderated level reached in the second half. A high tax rate will have a 2% impact on earnings, with constant currency earnings per share expected to be slightly ahead of the prior year.

Stefan Bomhard

executive
#27

When I look at what matters most to me in the year ahead, it comes down to three items: the correct strategy, the correct team, and the correct performance. Completing the strategic review and putting in place the right strategy to unlock the Group's full potential over time is my immediate priority. In January, I look forward to sharing more details. It is also about having the right people, blending the strengths of those already with us and the fresh perspective that new hires bring. The people in the business have impressed me, and that reinforces my confidence. I know many of you are watching today, and I want to thank you for your support so far. It is also about the right performance. To strengthen performance, I am already taking steps to improve accountability, with more rigorous, data led oversight. With a more disciplined focus on execution, I am confident we can start to deliver better and more consistent results. I am excited about the future and truly believe that, over time, we will deliver a stronger performance and unlock long term value for shareholders. Thank you very much for listening today. I would now like to take questions. I'll hand you back to the operator to start the Q&A session.

Operator

operator
#28

Thanks. Ladies and gentlemen, we’re going to start the question-and-answer portion now. <<operator_script>> Thank you. Our first question is from Owen Bennett at Jefferies. Your line is open, so please go ahead with your question.

Owen Bennett

analyst
#29

Morning, everyone. Trust you're doing well. So for the first question, I was hoping you might be able to talk about what's happening with blu in the U.S. and what steps you'll take to try to turn around the market share trends? To get more specific, obviously there's not much that can be done on the innovation front anytime soon, given new products and because of PMTA. So do you feel the blu product as it currently stands in the U.S. market is good enough? And how do you begin to generate some better momentum there? That's my first question. Thank you.

Stefan Bomhard

executive
#30

Owen, good morning — this is Stefan. It's a pleasure to meet you, even if only virtually. Regarding blu, and your question about U.S. market share: basically, what we've observed has been fairly encouraging, since market share for blu has been flattening over the past couple of months. So it's clear to us that the business is holding up well in today's conditions. As for the second part of your question, as you're aware, the future of our NGP strategy is what we're still working through right now as we prepare our overall strategy. So on that point, I apologize, but that's likely something — that's something we'll share on the 27th of January, at the Capital Markets Day.

Owen Bennett

analyst
#31

Thanks. I expect your reply to this will be much the same. I simply wanted to raise the topic of potentially divesting assets that aren't core to us. Are you considering that? More specifically, might you consider selling the mass markets cigars in the U.S., or perhaps a portion of the emerging market cigarette business? Thanks.

Stefan Bomhard

executive
#32

Owen, I believe you've framed that correctly. What I'd say is that, in principle, answering that before the strategic review wraps up wouldn't be appropriate. What I can assure you of, though, is that our review of the business is extremely rigorous, highly disciplined, and detailed — going unit by unit, brand by brand, and country by country. We'll therefore be examining our footprint assets along with performance and how execution measures up against it. That's genuinely something we'll return to with you at the end of January. Still, I can give you this assurance: every option within the business is being examined.

Owen Bennett

analyst
#33

All right, that's great. Many thanks. Thanks for making the time.

Operator

operator
#34

Thanks. The next question is from Gaurav Jain at Barclays. Go ahead, your line is open now.

Gaurav Jain

analyst
#35

Hello, good morning. I have a handful of questions. One thing that has worried investors a great deal is the margin reset at Imperial. You're issuing EPS guidance today, and there's a CMD coming in January. So should we take it that the guidance provided today will still stand in January? If you could comment on that, please?

Stefan Bomhard

executive
#36

Sure. Good morning, Gaurav. Gaurav, fundamentally, I think the main thing you're raising here—one thing to bear in mind is that if you compare how much is put into marketing in our industry specifically against other consumer goods sectors, we're talking about investment levels in the single digit range, whereas plenty of other consumer goods industries sit in the double digits. So overall, well, as I've reviewed the last four months and based just on what we know today, I think we're invested reasonably in our brands, in the right way. We're clearly also looking at how we spend that money today in terms of driving performance. So it's fairly reasonable to say, based on our knowledge, that you shouldn't expect a major margin reset—it won't be coming at the Capital Market Day.

Gaurav Jain

analyst
#37

Absolutely. You said in your remarks that you hold monthly business reviews with your top five markets. From what I understand, though, there are 10 key focus markets in total. So could you tell us which markets make up that top five? And as for the remaining five, does that mean they're no longer a focus?

Stefan Bomhard

executive
#38

Now, Gaurav, I think the key point — the wider picture is very clear, and during my first couple of months I had to sharply focus where I spend my time. It's quite evident that 5 of our leading markets contribute a very outsized share of our business results. So once those changes are in place, I hold monthly direct reviews with those top 5 markets along with the 2 divisions we have. So I'm not simply depending on 2 divisions to oversee the business — as the CEO of this company, I believe it matters a great deal to keep a direct grip on the business. We're also seeing — just to share one detail with you — it's not only with the Managing Director of the Market; it's with the whole management team, the Head of Sales, the Head of Marketing, the Head of Consumer Insights, because these are clearly the markets driving the strongest value creation. And the 5 markets you could work out when you look at this time — you will have seen it in our release. We call out the profitability and the revenue impact of these key markets. So probably, choose the top 5 markets from a revenue and a profit perspective, and you are in the right place.

Stefan Bomhard

executive
#39

To be clear, that doesn't mean the others don't matter. But I do think that focus here is among the main points I'm making — the market that's going to move the needle for this company.

Gaurav Jain

analyst
#40

Absolutely. For the final question, one that's more technical, perhaps regarding the excise tax situation. Australia and France have proven challenging markets over the past few years, since we faced those particularly sharp increases in excise tax. And it appears that in both of those nations, those cycles of excise tax increases are now concluding. So first, is that view accurate? And would that suggest Australia and France could see improvement for you, just as for everyone, across the next 2 years?

Oliver Tant

executive
#41

Gaurav, may I take that one? Hi, good morning — Oliver here. One factor you need to reflect on in Australia is that we've also benefited from — and we mentioned this at the end of last year — a duty windfall that forms part of those excise changes. Over the last couple of years, those have benefited our position in the market to the tune of about £50 million. So I think you actually — we expect that to largely unwind as we move forward. So we're starting from a lower base. So I would say with Australia, actually, that's likely to be a headwind for the business in the context of the outlook for FY21 and beyond. And France is progressing in a measured way — that's how I think I'd probably describe where we are in France.

Gaurav Jain

analyst
#42

Alright, thank you very much.

Operator

operator
#43

Thank you. Our following question is from Alicia Forry at Investec. Your line is open now, so please go ahead with your question.

Alicia Forry

analyst
#44

Hello there, good morning to you, Stefan, and—

Stefan Bomhard

executive
#45

Morning to you, Alicia.

Alicia Forry

analyst
#46

Hello. You discuss industry shifts frequently, and I believe much of that focuses on NGPs. However, I observed that a couple of years back, in 2018, during an Imperial company presentation, 70% of profit came from the top 10 markets. And within a couple of years from now, that has consolidated so the top five markets deliver 70% of profits. So I am just wondering whether you could address a few of the profitability shifts across your key markets that underlie this, that move and that concentration—I think that would be intriguing to learn more about. That is my first question.

Stefan Bomhard

executive
#47

Alicia, honestly, the reason is that I wasn't here in 2018, so it's quite hard for me to say anything about how profitability has developed over time. What I think is clear — and one takeaway I'm sure you have — is that, yes, it's very important that a significant chunk of our profit comes from a group of countries, and I'm focusing management's attention on those. At the same time, I'd also keep in mind that the rest of the market still contributes very meaningfully to this company. We're in the privileged position of having a good level of profitability here. But I think it's also very clear that a lot of our markets still make some very significant contributions to overall profitability. Oliver, anything you'd like to add from your side?

Oliver Tant

executive
#48

Yeah, I just had a couple of points. So I think we've actually seen pretty strong profitability growth from the five that we're focused on right now over that period. But it would also be fair to say that there was a big gap between the larger ones and the smaller ones, and so it was disproportionate. The increases in the larger ones contribute much more in overall terms. So if we take the U.S., for example, which has always been fairly transparent in our numbers, because we've talked about the Americas, and it's been a big chunk of our business, the profitability of that business has grown quite strongly over the last three or four years, and much stronger than the average for the Group as a whole. So it shouldn't come as a total surprise. And I guess it drives the comments Stefan's making about the need to be very focused on that group, because they make a massive difference if we get them wrong. And anyway, that's where a lot of the focus, time, and attention will be as we move forward.

Alicia Forry

analyst
#49

Got it, thanks. Second, when you mentioned becoming more agile, does that mean shifting where accountability sits inside the organization, or does it mean more spending on systems for monitoring data? Is this a structural and organizational matter, or is it more about capabilities and investment?

Stefan Bomhard

executive
#50

I think — let's say, that's a great question. One thing I can reassure you of is that it is not — the primary answer is that this isn't a structural investment in IT. I think it's more that we'll talk more about the Capital Markets Day once our work has been completed. It's a combination of, on one side, how do we focus our attention from the top down on the core markets and the core decisions. It is also logically a question of how we operate from a cultural perspective. I mean, you've seen that I've appointed Alison Clarke as the Head of People and Culture. There's a cultural opportunity here. And for example, introducing what you could call skip level management meetings with the top five markets, is one of these examples. That makes us significantly faster, so give you an example from these ones, in these meetings last month, we could very quickly take price decisions in a couple of our markets, because we suddenly had all the leadership team together of the company and we do this now on a monthly basis. And becoming more agile is going to be a combination of many things, but I feel very comfortable that we as an organization can become faster in our decision-making process.

Alicia Forry

analyst
#51

Thanks. And if I could squeeze in one final question, please. Could you discuss what the crisis has done to fine cut tobacco trends over the last few months? I'm just curious whether consumers are shifting more toward that product or moving away from it?

Stefan Bomhard

executive
#52

So first off, what's interesting is that fine cut tobacco holds a significant place in certain markets of ours, while in others it's a comparatively minor portion of our business — or of the industry overall. As a result, we really haven't observed any substantial shift in that area. The one instance I'd likely highlight in particular is that in certain markets, as borders closed, what you're seeing in the United Kingdom is that a big share of the market growth that's been reported has in fact taken place in fine cut tobacco. But when we examine — when I examine the more detailed data, it doesn't appear that consumers have traded down into fine cut tobacco. What we suspect right now is that a great deal of illicit trade is involved — consumers who had been purchasing illicit products have in fact moved over to fine cut tobacco. So we aren't — so that's a curious pattern, and we'll have to watch whether it's something that persists as time goes on or whether it swings back at some later point.

Alicia Forry

analyst
#53

I appreciate that.

Operator

operator
#54

Thanks. The next question is from Adam Spielman at Citi. Please go ahead, your line is open.

Adam Spielman

analyst
#55

Thanks so much, and I’m looking forward to getting to know the new top two. So, for my first question, I’m trying to frame it in a way that you can actually answer, right? And I suppose that, having listened very carefully to what you said, much of what you’ve described is more intense management—especially of the top five markets. And that stands in quite a big contrast to what we used to hear about under Alison Cooper. But the main strategy, or the low talk, was about streamlining Imperial, which I suppose meant asset sales. And I guess I thought personally, potentially buybacks. So here’s the question. The question is, am I right to assume that you believe there’s more value to be gained through intense management of the existing business, particularly the most profitable elements of it, relative to restructuring and streamlining the overall company?

Stefan Bomhard

executive
#56

Adam, as you mentioned — well, first of all, welcome, and I genuinely look forward to meeting you face to face too. And in trying to respond to that question today in November, well, logically the main answer is that this is among the central priorities for the Capital Markets Day. But to try to give you a sense of it — and I think you're reading that correctly — I do believe there's greater potential in managing core markets the right way. I think this company has some low hanging fruits, and that gives me confidence, because I see the underlying assets here resting on a solid base, particularly when we talk about the tobacco side. So I think that's clearly one of the opportunities I see. And I think it's in our shareholders' interest, because that clearly is going to deliver a relatively good return on this one. More details — I'm happy to share them at the end of January, when the strategic review is really complete, when I think it would be more appropriate to give you the fuller picture.

Adam Spielman

analyst
#57

Okay, and once more, I'll do my best to pose questions that you're able to respond to.

Stefan Bomhard

executive
#58

Yeah.

Adam Spielman

analyst
#59

Obviously, the share price is quite disappointing, to put it mildly. The valuation is really low, and you and everyone else are sharply aware of that. So I suppose the question is: do you believe that's something you can tackle head-on, most plainly by way of buybacks, or in your thinking is it something that, with solid operations, will simply resolve itself as time passes? And is your perspective that, give me 3, 4, 5 years, and hopefully operations will get better enough that the share price rises? Or, I suppose, is it a mix of those 2 things?

Stefan Bomhard

executive
#60

Adam, I’ll actually tackle this in two parts. First, I think it’s quite clear — and all of you are well aware — that when you look at how our relative share has performed, a secondary rating has plainly taken place over the last couple of years, and that hits us just as it hits many other players in the industry. But it’s also entirely fair to say, and I’ll be candid, that within the sector we as a company have underperformed, and the main reason for that is we have repeatedly failed to deliver against the expectations we set beforehand. So to some degree, what I hope — and I’m sure — you take from these results, and also from the outlook for fiscal ’21, is that from my side there is a clear strategic imperative that we make promises we can keep. You heard me speak earlier about a commitment being a commitment. So I think this matters. That is plainly one of the elements that I, together with the team here, want to use to get Imperial to a better place. Second, you are logically raising the question of capital allocation. On that one, I think we should begin with the strategy first.

Stefan Bomhard

executive
#61

That work is clearly underway, ensuring we provide the right amount of funding to genuinely let Imperial hold its place in this market for all the years ahead. Logically speaking — and that is exactly why I displayed it so plainly on the chart — at the end of January, we will lay out for you the company's capital allocation policy. During my last five years at Inchcape, we followed very clear capital allocation policies throughout that stretch. So we will give you clarity on how, grounded in the strategy, we intend to allocate capital going forward.

Adam Spielman

analyst
#62

Thanks. And I’d guess that when it comes to capital allocation, one consideration is how much leverage you want the company to carry. In the past, there has been a target of 2 to 2.5 times net debt-to-EBITDA. I assume you are at least considering whether that remains the right level, or whether it is the right level for the future?

Stefan Bomhard

executive
#63

Adam, it's part — absolutely. It's part of the capital allocation model, absolutely. And it's going to be is that — that combination of like, what is the right level of leverage for this company? What is the right level of dividend of the company and what, as you've mentioned before, is there an element of share buyback as we look at our capital allocation policy? So as I said before, all things are on the table as much on the strategy side as well as on the capital allocation side.

Adam Spielman

analyst
#64

Alright, thanks a lot. That's really useful.

Operator

operator
#65

Thanks. Our following question is from Patrick Dolan at Redburn. Your line is open now, so please go ahead with your question.

Patrick Dolan

unknown
#66

Good morning, gentlemen. I have two questions. First, looking specifically at Germany, if you consider how the shares have performed over the last few years, I mean, they've been struggling quite a bit. And this year, you had some favorable aspects with fewer losses, but you're still not where you want to be. In your view, Stefan, why has German performance been underwhelming, and do you have any insights into the channel and what that means for Imperial? And then secondly, on the mass market cigar business, good performance in H2 — how should we think about performance into 2021? Now we have the benefit of people staying at home over the last few months, and how should we think about the category over next year? Thank you.

Stefan Bomhard

executive
#67

And Patrick, good morning. Regarding how Germany is doing — I've now been in this business for four months. One thing I made certain of was to give the German market its due importance. In fact, I was over in Germany, on the ground, alongside our sales force and our management team, speaking with customers. Now, I think it would be inappropriate today to already be sharing thoughts of that kind about Germany. What's clear, I think, is the direction of travel — we want to reach a better position there. And I think — let me put it this way: for a large part of my career I've looked after German markets. I've been familiar with the German trade for a long period of time. There are, I think, some levers we can pull over time to get ourselves into a better position. And logically, as you'll know, there's a lot of value creation in our industry in the German markets. It's one of the most highly attractive markets, and we actually have a very strong footprint in the German markets, which is quite interesting and good for Imperial. But from a market share perspective, we do need to generate a better performance out of the German market.

Stefan Bomhard

executive
#68

It's going to require time; this won't be an overnight thing. Still, having been on the ground going through the plans alongside the team, I genuinely believe we have an opportunity to reach a better position. Turning to the mass market cigar question — the one you raised regarding the U.S. Clearly, we — obviously, that's an opportunity for Imperial to grow. I mean, given the backward brand we have in that market, that is clearly a consu — that's a brand with very strong consumer preference. So interestingly, in fiscal year '20 we were handicapped by supply constraints, since it uses a very high-quality leaf. And because of that, we couldn't actually produce as much as we wanted to. We're working very hard to improve our supply situation — to be clear, that carries wholesome cost of goods implications. But to be clear, there is consumer demand, a consumer preference for our brands, and so our job has to be getting these products into consumers' hands. To be clear, when you look at the half effects, we clearly have these supply chain shortages, primarily in half one of fiscal '20. So we already saw an improved situation in half two.

Stefan Bomhard

executive
#69

As we move into the first half of fiscal year '21, the year-on-year, like-for-like comparison should actually work out quite favorably for us. So I'm quite — you can probably tell that the mass market cigar opportunity in the U.S. has me quite excited.

Patrick Dolan

unknown
#70

That’s great — thanks very much.

Operator

operator
#71

Thanks. The next question is from Jon Leinster at SocGen. Jon, your line is open — go ahead and ask.

Jon Leinster

analyst
#72

Morning, and thanks. Again, Adam, just to say it once more — I'm looking forward to meeting you face to face at some point. I have a couple of questions, if I may. First, on your outlook: you mentioned that volumes would become more normalized. Could you expand a little on what you expect for the U.S. and EU markets in terms of volumes as we go into FY21, please?

Stefan Bomhard

executive
#73

It's a great question, and I have to say predicting this is tough. Honestly, what I'd say is this: if you look at the U.S. and Europe, we clearly saw underlying market volumes improve behind COVID. From a volume standpoint in those markets, I think COVID has been a tailwind. It's fair to say that in our fiscal year '21, some of that tailwind will unwind. Honestly, it's hard for me to say by how much, because that will depend on when the effect of COVID is going to reduce itself. And to be fair, it also depends on what the recessionary impact from COVID will be. So I feel quite confident that we'll see some unwind of the tailwind. But it's quite difficult to say how much will really happen in fiscal year '21. And personally — you probably get the sense — I'd rather go forward with a prudent forecast than lean forward in an optimistic way here. If the world turns out to be better, fantastic for all of us.

Stefan Bomhard

executive
#74

However, I’d rather not have my forecast rest on what you might call a highly optimistic outlook.

Jon Leinster

analyst
#75

Alright. And maybe I could ask essentially the same thing in a somewhat different way. In your view, how much of an effect did illicit trade—or its absence—have on several of the biggest markets? And are you working on the assumption that illicit trade returns to the market at something like a more normalized rate?

Stefan Bomhard

executive
#76

Honestly, I think that's a pretty tough question, because as you're aware, illicit trade is really hard to track right now. To address your broader question — would I expect some recovery in illicit trade if the border situation normalizes? Yes, I believe we would see that. Would it get back to where it was before? At this point, I'd say that's hard to determine.

Jon Leinster

analyst
#77

All right. Now regarding NGP, it seems the run-rate cost base comes to roughly £400 million annually. Of that amount, what portion would you describe as fixed, and what portion is marketing and variable? Can you flex that going forward?

Stefan Bomhard

executive
#78

Honestly, at this point I wouldn't really break things out by the individual P&L lines of the NGP business. I think — you're right that there have been a lot of moving parts in the past. So that's honestly one of the items I'd prefer to revisit at the end of January, since we're still working through our plans. But what you will see is a more focused and more rigorous approach. One thing I would offer to you is that historically it's been a fairly fragmented approach, as we've run our EVP business separately from our heated tobacco efforts. For example, and one of the steps I've taken in my first months is to actually bring that business much closer together. So we're removing duplication of market research costs, as an example, because an NGP consumer is an NGP consumer, we don't need to do the research twice between heated tobacco and EVP.

Jon Leinster

analyst
#79

Okay, and one last thing, if I can — you brought up again, regarding capital allocation, that you're putting more money specifically into the tobacco sales force. Is that — I'm not presuming anything, but is there some kind of easy win there? Is that an area where you could turn around the market share trajectory in certain key markets, simply because maybe the sales force hasn't been large enough?

Stefan Bomhard

executive
#80

As I mentioned, I've spent a good chunk of my career running sales forces. Having been in the field alongside our teams and having examined how we cover various channels and so forth, I believe we have room to strengthen how we cover the channels that offer the most appeal. We'll share more specifics at Capital Markets Day, but I genuinely see that as one of the levers available to us for running our business better. And just as you put it, at the end of the day that's one of the levers we can pull in order to drive market share too.

Oliver Tant

executive
#81

It may be worth making that point clear. What actually happened in FY20 is that we had — we put a lot of investment behind our NGP business in FY19 and into the early part of '20. Part of that was the sales force, so the sales force was given a series of initiatives to support NGP. What we did over the course of '20 was cut back the time they devoted to NGP and ask them to devote more time to tobacco. So while that appears as a rise in our tobacco costs, clearly the offset is that it brought our NGP costs down. We have not added overall costs of £26 million.

Jon Leinster

analyst
#82

Right, okay. So I mean, but okay, so it comes down to how things are allocated.

Oliver Tant

executive
#83

Yeah, well, it comes down to how time gets allocated. You can see that's —

Stefan Bomhard

executive
#84

Regarding fiscal '20.

Oliver Tant

executive
#85

Regarding fiscal year 2020.

Jon Leinster

analyst
#86

Yeah. All right. Well, I really appreciate it.

Stefan Bomhard

executive
#87

Appreciate it.

Operator

operator
#88

Thanks. The next question is from James Edwardes Jones at RBC. You can go ahead now — your line is open.

James Edwardes Jones

analyst
#89

Morning. Stefan, you mentioned that decisions should rest on actual data and insights—that was your wording, I believe. And the implication came through quite clearly that historically this hasn't happened. Could you share some instances of what is changing or what has to change?

Stefan Bomhard

executive
#90

Sure, I think there are two <<inaudible>>. The clearest example, I'd say, is NGP. It's quite evident that, with the best of intentions previously, a number of our NGP launches moved too quickly and spread too widely. And because we wanted to seize what was, particularly on the EVP side, a market expanding very rapidly, and in heated tobacco as well, there were occasions when choices got made before the complete data was on hand. Products were then scaled into markets without truly having all the information available — so the proposition wasn't fully tested. That would be one. The second thing I'd offer is that, when you look at it, I've gone through hundreds of pages of consumer data covering our tobacco business. What I noticed was plenty of data, but, for instance, the way we examine some of it isn't consistent company-wide. And it's the mining of that data within the decision-making process where I believe we have a genuine opportunity to do better. That makes me confident that, over time, we can also lift our tobacco performance.

James Edwardes Jones

analyst
#91

Understood, thanks.

Operator

operator
#92

Thanks. The next question is from Sanath Sudarsan at Morgan Stanley. Go ahead, your line is open.

Sanath Sudarsan

analyst
#93

Morning, everyone — thanks for joining. And Stefan, good to hear from you. I've got two questions for you today.

Stefan Bomhard

executive
#94

Morning, everyone.

Sanath Sudarsan

analyst
#95

Okay, good morning — I’ve got two questions for you today. First, it looks like you’ve examined every option within the business, and a lot of what you’ve said points toward enhancing operational performance, speed, and accountability, for example. But the tobacco industry is shifting considerably, particularly in several of your key markets. So how do you reconcile your internal review of the business with the external market, given your current brand and geographic footprint? And second, probably tied to that: do you believe Imperial can become a business that brings more users into the portfolio — in other words, can the canvas turn into a growth business over the medium to long term? Thank you.

Stefan Bomhard

executive
#96

Sanath, I think logically my starting point has to be the business I have today. So my strategic review must begin with today's business. But logically, we're doing this in the context mode of what will the industry look like in the next five years? So you have to trust me that we are looking at all options, and we're considering that. But to be clear, I think there is clearly an opportunity to generate more growth and more profitability from our existing portfolio, but we're not going to close our eyes to other opportunities that are there. But to be clear, I think our starting point always has to be our own business. And we'll give you more details on this once we have completed our strategic review at the end of January.

Sanath Sudarsan

analyst
#97

Okay, and let me just follow up with one more question about the culture shifts you've actually mentioned. And of course, culture shifts are always part of a company's transformation story. Could you maybe also share a few additional examples of how the traditional versus new culture model can help deliver somewhat more robust earnings for the business?

Stefan Bomhard

executive
#98

I think — I genuinely believe culture can be a key factor. I mean, over my last five years as CEO, it definitely made a difference. And I think one thing you can take as a signal — me, for the first time in quite a while, putting an achieve people and culture office on the Executive Committee — take that as a signal that I do see that as one of the key levers of improved performance at Imperial. And I think the other thing: when I went through all the employee engagement service, read through all the verbatims from a survey that was done before I arrived, it's very clear there is an observation from an employee that we work too much in silos. And when you hear the word silo, that's a very clear signal we're wasting resource because people do not work together enough. And therefore you have duplication in the organization. So that is clearly — I see a more collaborative culture throughout the business. And also with more shared objectives as an organization, that's one of the levers to pull in this context. And I've done this before in my career. I do believe there is actually going to be a very high correlation between driving a more collaborative and more focused culture in the organization to actually making a contribution to a more consistent performance of the company.

Stefan Bomhard

executive
#99

Still, Alison will cover that with you once we reach the close of January.

Sanath Sudarsan

analyst
#100

Thanks a lot.

Operator

operator
#101

Thanks. There are no more questions right now, so please continue.

Stefan Bomhard

executive
#102

All right, I want to express real appreciation for such a strong batch of questions. And as I mentioned earlier, hopefully there will be an opportunity for us to get together in person once more. And I'm really looking forward to hopefully — at least probably virtually — seeing you at the end of January, when we — I'm confident that lots of the questions you weren't able to raise today, we'll be in a position to address those. Thank you.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Imperial Brands PLC transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Imperial Brands PLC earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Imperial Brands PLC or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.